September 4, 2010
| Bio-IT World > Drug Discovery

Drug Discovery

Loading...

Change page: < >  |  Displaying page 2 of 95, items 11 to 20 of 947.

Ion Torrent Gives Two Sequencers Away in Europe

Bio-IT World | Ion Torrent has extended its Ion PGM (Personal Genome Machine) Sequencer Grant Program to Europe, and will award two sequencers to scientists there in the second half of 2010. In April, Ion Torrent gave two PGM sequencers to John Iafrate and Long Le from Massachusetts General Hospital’s (MGH) pathology department and Mitchel Sogin from Woods Hole.

New Washington-Area Biotech Formed

Washington Business Journal | Noble Life Sciences has been created by former executives from Avalon Pharmaceuticals and CoGenesys.

Illumina Drops Personal Genome Sequencing Price to Below $20,000

Bio-IT World | One year after Illumina introduced its personal genome sequencing service, CEO Jay Flatley announced a significant price drop for individual human genome sequencing to below $20,000, and potentially half that if there is clinical relevance.

GnuBio Enters Next-Generation Sequencing Sweepstakes

Bio-IT World | GnuBio, the latest entry in the next-generation sequencing sweepstakes, made its public debut at the Consumer Genetics Show today, offering the prospect of a $30 human genome.

 

A New Rap for Chemistry

Bio-IT World | ‘Computational chemistry got a bad rap early on because it wasn’t necessarily as predictive as it might have been,” says David Pompliano, CEO of BioLeap. “We’re on the cusp of something very different.”

2010 New Technology Survey Results

Bio-IT World | Results of the Drug Safety Executive Council survey show that the most popular types of technologies biopharmaceutical companies are already spending resources to evaluate are: High content tox assays or high throughput cell health profiles; Alternative in vitro assessments of cardiovascular risk; and Toxicity biomarkers.

2010 Best of Show Awards

Bio-IT World | The Best of Show Awards Program at Bio IT World recognizes innovative solutions to important problems facing the Life Sciences industry, and this year’s program saw a record 43 entries from 42 companies These are this year’s finalists and winners.

Genentech, Complete Genomics Sequence Primary Lung Tumor Genome

Bio-IT World |  Genentech and Complete Genomics have published the first full genome sequence of a primary lung tumor from a heavy smoker, leading to the calculation that one DNA mutation is triggered for every three cigarettes smoked. 

 

Rhythm and Blues: The Case for Allosteric Modulators

Bio-IT World | The vast majority of drugs on the market act by competing directly with the target’s natural ligand for the protein’s active site. But a handful of marketed molecules—Amgen’s hyperparathyroidism drug cinacalcet and Pfizer’s HIV inhibitor maraviroc are two examples—show the potential of a new class of drugs: allosteric modulators.

A Social Approach to Patient Recruitment

Bio-IT World | Better use of Web 2.0 sites like Twitter, Facebook and PatientsLikeMe could be a boon for enrollment. 



White Papers & Special Reports

ClearTrial_BriefingOn
eClinical Trial Technologies Revolutionizing Clinical Development Efficiency
Sponsored by ClearTrial
This Bio-IT World BriefingON report, sponsored by ClearTrial, presents a selection of recent stories from Bio•IT World and sister publication, eCliniqua, that illustrate how new technologies and approaches can have a profound impact on the management and execution of clinical trials.


oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



bluearc_whitepaper0710
Breaking Through Real World Storage Barriers in Next Generation Sequencing
Sponsored by BlueArc

To effectively and efficiently manage the rapidly increasing needs of an NGS research environment numerous considerations for data management become important in moving today’s terabyte and petabyte levels of data. Some key concerns can include:

  • Maintaining enough  headroom to handle additional and unplanned data growth
  • How to address mixed workloads
  • Working with multiple file and network protocols
  • Dealing with aging data
  • Optimizing varied storage subsystems already in place while preparing for new floods of data to come

This paper investigates trends and solutions in addressing these issues, and more, for life science professionals.



Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Web Symposia
Loading...

Bio-IT World proudly presents the Bio-IT World Web Symposia Series!

Covering a broad array of topics within the life sciences and drug development industries, these complimentary 90-minute web symposiums provide an interactive platform to learn more about cutting-edge bio-IT topics through expert analysis and discussions.

Leveraging BPM to Increase Efficiencies in Clinical Trial Case Management
Recorded on August 3, 2010
Sponsored by: Pegasystems
Program Details | Access Recording 

Next Gen Data Management for Next Gen Life Sciences
September 8, 2010 | 1:00pm - 2:30pm EST
Sponsored by Quantum
Program Details | Register Today 

 





Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.